Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Cellular/Molecular

Aberrant Formation of Glutamate Receptor Complexes in Hippocampal Neurons of Mice Lacking the GluR2 AMPA Receptor Subunit

Nathalie Sans, Bryce Vissel, Ronald S. Petralia, Ya-Xian Wang, Kai Chang, Gordon A. Royle, Chang-Yu Wang, Steve O'Gorman, Stephen F. Heinemann and Robert J. Wenthold
Journal of Neuroscience 15 October 2003, 23 (28) 9367-9373; DOI: https://doi.org/10.1523/JNEUROSCI.23-28-09367.2003
Nathalie Sans
1Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland 20892-8027, 2Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and 3Garvan Institute of Medical Research, Darlinghurst NSW 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryce Vissel
1Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland 20892-8027, 2Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and 3Garvan Institute of Medical Research, Darlinghurst NSW 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald S. Petralia
1Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland 20892-8027, 2Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and 3Garvan Institute of Medical Research, Darlinghurst NSW 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ya-Xian Wang
1Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland 20892-8027, 2Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and 3Garvan Institute of Medical Research, Darlinghurst NSW 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai Chang
1Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland 20892-8027, 2Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and 3Garvan Institute of Medical Research, Darlinghurst NSW 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon A. Royle
1Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland 20892-8027, 2Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and 3Garvan Institute of Medical Research, Darlinghurst NSW 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chang-Yu Wang
1Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland 20892-8027, 2Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and 3Garvan Institute of Medical Research, Darlinghurst NSW 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve O'Gorman
1Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland 20892-8027, 2Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and 3Garvan Institute of Medical Research, Darlinghurst NSW 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen F. Heinemann
1Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland 20892-8027, 2Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and 3Garvan Institute of Medical Research, Darlinghurst NSW 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert J. Wenthold
1Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland 20892-8027, 2Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, and 3Garvan Institute of Medical Research, Darlinghurst NSW 2010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Generation and analysis of a GluR2 knock-out mouse. A, I, Allele generated by homologous recombination of the GluR2-targeting construct, showing the loxP sites that surround exon 11 and Neo inserted in the intron between exons 11 and 12. Exons 10, 11, and 12 are also shown. II, LoxP sites are indicated by open arrows; these contain BamHI restriction sites in the loxP cassette. 5′ and 3′ probes used for Southern blotting are shown as gray shaded boxes. B, BamHI; S, Spel. B, Southern blots demonstrating successful insertion of the construct at the targeted site. A 12.5 Kb BamHI fragment and 5.5 Kb SpeI fragment are seen in the wild-type mouse with the 5′ probe (lanes 1, 2). Excision of the floxed fragment in the knock-out (-) allele moves the SpeI site closer to the 5′ probe, resulting in a 3.5 Kb fragment (lane 4). Insertion of the loxP cassette BamHI restriction site shortens the BamHI fragment seen by the 3′ probe to 6 Kb in the knock-out allele (lane 6). C, RNase protection assay for exon 11 of the GluR2 allele, demonstrating loss of expression of the GluR2-deleted region in the global knock-out animal (-/-) and normal expression in wild-type (+/+) animals. Sense probe control is included (sense). RNA extracted from whole brains is shown. D, Hippocampus proteins from GluR2+/+, GluR2+/-, and GluR2-/- mice (10 μg per lane) were analyzed by SDS-PAGE and immunoblotted with the C terminus polyclonal antibody indicated. Samples analyzed with different antibodies were obtained from the same preparation of the hippocampus. Histograms show the relative average amount of protein (percentage of GluR2+/+) of three sets of experiments. Levels were measured by densitometric scanning of Western blots.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Immunoprecipitation of AMPAR subunits (bound fraction). Ten microliters of bound immunoprecipitate fractions was separated by SDS-PAGE, immunoblotted, and incubated with the indicated C terminus polyclonal antibodies.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    AMPAR subunits remaining (unbound fraction) after immunoprecipitation of detergent-solubilized hippocampal neurons from GluR2+/+, GluR2+/-, and GluR2-/- mice. The two left lanes of each panel show the nonimmunoprecipitated Triton-solubilized fraction (Tx sol). The 100% lane represents 10 μl of sample applied, whereas the 5% lane represents 0.5 μl of sample applied (after 1:10 dilution with sample buffer). These lanes represent the range of labeling for quantification of immunoreactivity in the depleted fractions. For each gel, standards of 75, 50, 25, and 10% of the solubilized fraction were also analyzed (data not shown). To determine the amount of immunoprecipitated proteins, after GluR1, GluR2-R3, GluR4, GluR1 plus GluR2-R3, GluR1 plus GluR4, and GluR2-R3 plus GluR4 immunoprecipitation (as indicated on top), 10 μl of the depleted fraction was analyzed, equivalent to an equal volume of the solubilized fraction (100%). The percentage of immunostaining remaining in the depleted fractions is shown below each band (mean ± SEM of three separate experiments).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    A, B, C, Immunogold localization of AMPARs in the CA1 stratum radiatum of GluR2+/+ (WT) and GluR2-/- (KO) mice, using GluR2-R3 (A), GluR1 (B), and GluR3 (C) antibodies. Note that in these micrographs, there is less gold labeling in GluR2-/- than in GluR2+/+ mice. D, Double labeling for GluR1 (10 nm gold particles) and GluR3 (5 nm gold particles). Arrowheads indicate 5 nm of gold in the postsynaptic process. Arrows in A--D indicate postsynaptic membranes or densities. Scale bars: A-C, 200 nm; D, 100 nm. E, Quantification of gold labeling for gold per synapse using GluR2/3, GluR2, GluR3, and GluR1 antibodies expressed as the percentage decrease in GluR2-/- mice, relative to GluR2+/+ mice.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Immunogold localization with GluR2/3 antibody on interneuron synapses [i.e., found on a dendrite shaft (den), compared with spine synapses, in two GluR2-/- animals]. Arrowheads indicate postsynaptic labeling. Note that the labeling is prevalent in the dendrite shaft synapses but not in the spine synapses. Scale bar, 200 nm.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Intracellular receptors in GluR2+/+ and GluR2-/- mice. A, Glycosylation state of AMPARs in the GluR2+/+ and GluR2-/- mice. Membrane homogenates from the hippocampus of GluR2+/+ and GluR2-/- mice were solubilized with 0.5% SDS in the presence of 1% β-mercaptoethanol. After dilution with 1% NP-40, soluble extracts were incubated in the absence of enzyme (control samples) or in the presence of Endo-H or PNGaseF. GluR1 and GluR3 have a small but distinct population that is Endo-H sensitive in the GluR2+/+ and GluR2-/- mice. B, Quantification of gold labeling per square micrometer using GluR1 antibody in the cell body (light gray; n = 38 for GluR2+/+; n = 35 for GluR2-/-; p = 0.96) and dendrites (dark gray; n = 21 for GluR2+/+; n = 17 for GluR2-/-; p = 0.50) of GluR2+/+ and GluR2-/- mice. C-J, Representative micrographs of GluR1 labeling in the cell body of GluR2+/+ (C,D) and GluR2-/- (G,H) mice and in dendrites of GluR2+/+ (E,F) and GluR2-/- (I,J) mice. Arrowheads indicate labeling associated with ER or reticular-like structures. Scale bar, 200 nm.

Tables

  • Figures
    • View popup
    Table 1.

    Quantification of immunogold localization of AMPA receptors in the CA1 stratum radiatum

    Antibody Animal CA1-stratum radiatum gold per synapse Number of synapses
    GluR2 gold per synapse WT (2 animals; 2 experiments using 1 antibody) 0.13 480
    KO (2 animals; 2 experiments using 1 antibody) 0.005 372
    GluR2/3 gold per synapse WT (2 animals; 4 experiments using 1 antibody) 1.23 860
    KO (2 animals; 4 experiments using 1 antibody) 0.18 856
    GluR3 1/100 gold per synapse WT 2 animals 0.25 460
    KO 2 animals 0.18 385
    GluR3 1/25 gold per synapse WT 2 animals 0.55 379
    KO 2 animals 0.41 339
    GluR1 gold per synapse WT (3 animals; 7 experiments using 2 antibodies) 0.55 1346
    KO (3 animals; 7 experiments using 2 antibodies) 0.31 1324
    GluR1 gold per micrometer WT (3 animals; 3 experiments using 2 antibodies) 3.5 641
    KO (3 animals; 3 experiments using 2 antibodies) 2.2 664
    Control WT (1 animal; 1 experiment using 1 antibody) 0 117
    KO (1 animal; 1 experiment using 1 antibody) 0 109
    • All differences between WT (GluR2+/+) and KO (GluR2−/−) are highly significant, except for GluR3, for which the decreases in KOs are slightly significant (p<0.05 for 1/100; p<0.02 for 1/25). Average synapse length for GluR1-labeled sections is 0.20 μm (n=641) and 0.19 μm (n=664) for WT and KO, respectively. This 5% decrease in length is significant. For the latter study, the same area of neuropil was examined (>2000 μm2) for WT and KO, although the area contributed by large structures, especially dendrites, was not subtracted. This indicates that there are, at most, only small changes in synapse number and length.

Back to top

In this issue

The Journal of Neuroscience: 23 (28)
Journal of Neuroscience
Vol. 23, Issue 28
15 Oct 2003
  • Table of Contents
  • About the Cover
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Aberrant Formation of Glutamate Receptor Complexes in Hippocampal Neurons of Mice Lacking the GluR2 AMPA Receptor Subunit
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Aberrant Formation of Glutamate Receptor Complexes in Hippocampal Neurons of Mice Lacking the GluR2 AMPA Receptor Subunit
Nathalie Sans, Bryce Vissel, Ronald S. Petralia, Ya-Xian Wang, Kai Chang, Gordon A. Royle, Chang-Yu Wang, Steve O'Gorman, Stephen F. Heinemann, Robert J. Wenthold
Journal of Neuroscience 15 October 2003, 23 (28) 9367-9373; DOI: 10.1523/JNEUROSCI.23-28-09367.2003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Aberrant Formation of Glutamate Receptor Complexes in Hippocampal Neurons of Mice Lacking the GluR2 AMPA Receptor Subunit
Nathalie Sans, Bryce Vissel, Ronald S. Petralia, Ya-Xian Wang, Kai Chang, Gordon A. Royle, Chang-Yu Wang, Steve O'Gorman, Stephen F. Heinemann, Robert J. Wenthold
Journal of Neuroscience 15 October 2003, 23 (28) 9367-9373; DOI: 10.1523/JNEUROSCI.23-28-09367.2003
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • AMPA receptors
  • assembly
  • GluR2 knock-out mouse
  • hippocampus
  • glutamate receptors
  • immunoprecipitation

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Acute ethanol modulates synaptic inhibition in the basolateral amygdala via rapid NLRP3 inflammasome activation and regulates anxiety-like behavior in rats
  • KCNQ2/3 Gain-of-Function Variants and Cell Excitability: Differential Effects in CA1 versus L2/3 Pyramidal Neurons
  • Tonic activation of NR2D-containing NMDARs exacerbates dopaminergic neuronal loss in MPTP-injected Parkinsonian mice
Show more Cellular/Molecular
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.